SLEEP NUMBER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.18 USD | -0.35% |
|
+4.19% | -4.38% |
| Apr. 25 | UBS Adjusts Sleep Number Price Target to $13 From $12, Maintains Neutral Rating | MT |
| Apr. 25 | Piper Sandler Adjusts Price Target on Sleep Number to $13 From $12, Keeps Neutral Rating | MT |
Strengths
- The stock, which is currently worth 2024 to 0.14 times its sales, is clearly overvalued in comparison with peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Home Furnishings
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -4.38% | 317M | C | ||
| -2.06% | 8.67B | B | ||
| -4.20% | 3.79B | C- | ||
| +5.08% | 2.22B | C | ||
| +6.69% | 1.8B | - | ||
| -10.32% | 1.41B | B- | ||
| -27.03% | 1.18B | C+ | ||
| +28.08% | 1.13B | - | ||
| +4.35% | 928M | - | ||
| -2.98% | 816M | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SNBR Stock
- Ratings Sleep Number Corporation
